The latest biotech news

News and Trends 11 Oct 2022

Muna Therapeutics gets $4.9M grant for Parkinson’s disease research

Muna Therapeutics has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The grant will be used to support ongoing preclinical research and development of novel, brain-exposed, small molecule potassium channel type 1.3 (Kv1.3) blockers to abrogate neuroinflammation driven by disease-associated microglia and enhance neuroprotection as a disease-modifying […]

October 11, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 11 Oct 2022

Positive results from NMD Pharma myasthenia gravis trial

NMD Pharma A/S has reported positive top-line results from its phase I/IIa clinical trial of NMD670, recently granted orphan drug designation by the FDA for treatment of myasthenia gravis (MG). NMD670 was safe and well tolerated in healthy volunteers and patients. Administration of single doses of NMD670 was associated with clinically significant improvements in the […]

October 11, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 11 Oct 2022

Clinical Microbiomics expanding with €10M million investment

Danish microbiome research company Clinical Microbiomics A/S has received €10 million ($9.7 million) in funding from Seventure Partners. Clinical Microbiomics, founded in 2015, is a microbiome analysis company, which includes work on clonal-level microbiome profiling. The company is working with food and consumer health companies and is supporting the pharmaceutical industry in phase 3 clinical […]

October 11, 2022 - 2 minutesmins - By Jim Cornall

More News! 10 Oct 2022

Positive data indicates likely therapeutic effect of Alzheimer’s drug

Positive phase 2a clinical data from an Alzheimer’s disease (AD) biomarker study, has been announced today (October 10). Actinogen Medical Limited shared the news that its study validates its planned program for Xanamem, a potential drug for the disease. The biomarker study was conducted in 72 patients with available blood biomarker samples from the prior […]

October 10, 2022 - 3 minutesmins - By Liza Laws

News and Trends 10 Oct 2022

Fast track designation for Nanoscope Therapeutics’ retinitis pigmentosa treatment

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, says the U.S. Food and Drug Administration (FDA) has granted fast track designation (FTD) to MCO-010. MCO-010 is an ambient-light activatable multi-characteristic opsin (MCO) optogenetic monotherapy to restore vision in blind patients, for the treatment of retinitis pigmentosa (RP) via intravitreal […]

October 10, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 10 Oct 2022

JW Therapeutics receives approval for relapsed or refractory follicular lymphoma drug

China’s National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for JW Therapeutics’ anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product relmacabtagene autoleucel injection. Also known as relma-cel, the product has the trade name Carteyva. It is used for the treatment of adult patients with follicular lymphoma that is […]

October 10, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 10 Oct 2022

Evonik and Phathom Pharmaceuticals partner on novel acid-blocker vonoprazan

Evonik has entered into a long-term supply agreement with Phathom Pharmaceuticals, a U.S. biopharma company developing and commercializing new treatments for gastric acid-related diseases. Evonik will produce large-scale volumes of vonoprazan at its FDA-inspected manufacturing sites in Tippecanoe, Indiana, U.S., and Dossenheim, Germany. “The manufacture of vonoprazan requires multi-step syntheses involving complex chemistries. We are […]

October 10, 2022 - 2 minutesmins - By Jim Cornall

More News! 10 Oct 2022

RadioMedix announces a $40 million series A financing for targeted alpha therapy platform

A company committed to advancing treatments for rare and aggressive cancers has received a series A funding of $40 million. Clinical stage biotech, RadioMedix, Inc. announced the agreement with an entity related to Portland Investment Counsel Inc. (Portland), on Friday (October 7). RadioMedix is committed to the advancement of a targeted alpha therapy (TAT) pipeline […]

October 10, 2022 - 3 minutesmins - By Liza Laws

News and Trends 10 Oct 2022

Trial starts for treatment of warm autoimmune hemolytic anemia

China-based Hutchmed has started a phase 2/3 trial of sovleplenib in adults with a disorder called warm antibody autoimmune hemolytic anemia (wAIHA). The autoimmune disorder can lead to anemia and currently has limited treatment options. It causes premature destruction of healthy red blood cells and the rate of production of new cells in the bone […]

October 10, 2022 - 2 minutesmins - By Liza Laws

News and Trends 10 Oct 2022

Biocartis starts European commercialization of liver cancer test

Biocartis Group NV has started the commercialization in Europe of the HepatoPredict test as a CE-IVD marked manual kit. The test, developed by Portuguese biotech company Ophiomics, is a prognostic diagnostic test that supports the decision of liver transplantation in patients with hepatocellular carcinoma (HCC). Herman Verrelst, chief executive officer of Biocartis, said: “We are […]

October 10, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 10 Oct 2022

Chinese company sees approval for diabetes drug

Hua Medicine says its new drug application (NDA) for HuaTangNing (dorzagliatin tablets) has been approved by the National Medical Products Administration (NMPA) in China. HuaTangNing is a first-in-class glucokinase activator (GKA) developed by the company. The approval is for two indications, both to improve blood glucose control for type 2 diabetes (T2D) patients, as monotherapy […]

October 10, 2022 - 6 minutesmins - By Jim Cornall

News and Trends 10 Oct 2022

Saudi university study could pave way for new cancer drugs

Precise details of how a master regulator of gene expression binds its activating partner could open new avenues for cancer drug development. The findings were made at the King Abdullah University Of Science And Technology in Saudi Arabia. They reveal how the activating partner, a small cellular metabolite and signaling molecule called PI5P, interacts simultaneously […]

October 10, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Muna Therapeutics gets $4.9M grant for Parkinson’s disease research

Positive results from NMD Pharma myasthenia gravis trial

Clinical Microbiomics expanding with €10M million investment

Positive data indicates likely therapeutic effect of Alzheimer’s drug

Fast track designation for Nanoscope Therapeutics’ retinitis pigmentosa treatment

JW Therapeutics receives approval for relapsed or refractory follicular lymphoma drug

Evonik and Phathom Pharmaceuticals partner on novel acid-blocker vonoprazan

RadioMedix announces a $40 million series A financing for targeted alpha therapy platform

Trial starts for treatment of warm autoimmune hemolytic anemia

Biocartis starts European commercialization of liver cancer test

Chinese company sees approval for diabetes drug

Saudi university study could pave way for new cancer drugs

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!